P62 binding to protein kinase C ζ regulates tumor necrosis factor α-induced apoptotic pathway in endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 12, 2012, Pages 2974-2980

  Kim, Geun Young ^a   Nigro, Patrizia ^a   Fujiwara, Keigi ^a   Abe, Jun Ichi ^a   Berk, Bradford C ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

apoptosis; endothelial cells; p62; Phox Bem1p domain; protein kinase C

Indexed keywords

CASPASE 3; PROTEIN KINASE C ZETA; PROTEIN P62; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

APOPTOSIS; CASPASE 3; CELL LINE; ENDOTHELIUM, VASCULAR; HUMANS; MAP KINASE KINASE 4; PROTEIN BINDING; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-MYC; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84870052776     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.300054     Document Type: Article

References (40)

1. Garin G, Abe J, Mohan A, Lu W, Yan C, Newby AC, Rhaman A, Berk BC. Flow antagonizes TNFalpha signaling in endothelial cells by inhibiting caspasedependent PKC zeta processing. Circ Res. 2007;101:97-105. (Pubitemid 47094628)
2. Heo KS, Lee H, Nigro P, Thomas T, Le NT, Chang E, McClain C, ReinhartKing CA, King MR, Berk BC, Fujiwara K, Woo CH, Abe J. PKCζ mediates disturbed flowinduced endothelial apoptosis via p53 SUMOylation. J Cell Biol. 2011;193:867-884.
3. Spindel ON, Yan C, Berk BC. Thioredoxininteracting protein mediates nucleartoplasma membrane communication: role in vascular endothelial growth factor 2 signaling. Arterioscler Thromb Vasc Biol. 2012;32:1264-1270.
4. Rennier K, Ji JY. Shear stress regulates expression of deathassociated protein kinase in suppressing TNFainduced endothelial apoptosis. J Cell Physiol. 2012;227:2398-2411.
5. Nigro P, Satoh K, O'Dell MR, Soe NN, Cui Z, Mohan A, Abe J, Alexis JD, Sparks JD, Berk BC. Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein Edeficient mice. J Exp Med. 2011;208:53-66.
6. Magid R, Davies PF. Endothelial protein kinase C isoform identity and differential activity of PKCzeta in an atherosusceptible region of porcine aorta. Circ Res. 2005;97:443-449. (Pubitemid 41298174)
7. Tricot O, Mallat Z, Heymes C, Belmin J, Lesèche G, Tedgui A. Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. Circulation. 2000;101:2450-2453. (Pubitemid 30366245)
8. Nigro P, Abe J, Woo CH, Satoh K, McClain C, O'Dell MR, Lee H, Lim JH, Li JD, Heo KS, Fujiwara K, Berk BC. PKCzeta decreases eNOS protein stability via inhibitory phosphorylation of ERK5. Blood. 2010;116:1971-1979.
9. Rosse C, Linch M, Kermorgant S, Cameron AJ, Boeckeler K, Parker PJ. PKC and the control of localized signal dynamics. Nat Rev Mol Cell Biol. 2010;11:103-112.
10. Hirano Y, Yoshinaga S, Ogura K, Yokochi M, Noda Y, Sumimoto H, Inagaki F. Solution structure of atypical protein kinase C PB1 domain and its mode of interaction with ZIP/p62 and MEK5. J Biol Chem. 2004;279:31883-31890. (Pubitemid 39037861)
11. Nakamura K, Johnson GL. PB1 domains of MEKK2 and MEKK3 interact with the MEK5 PB1 domain for activation of the ERK5 pathway. J Biol Chem. 2003;278:36989-36992. (Pubitemid 37175211)
12. Lamark T, Perander M, Outzen H, Kristiansen K, Øvervatn A, Michaelsen E, Bjørkøy G, Johansen T. Interaction codes within the family of mammalian Phox and Bem1p domaincontaining proteins. J Biol Chem. 2003;278:34568-34581. (Pubitemid 37553306)
13. Sanchez P, De Carcer G, Sandoval IV, Moscat J, DiazMeco MT. Localization of atypical protein kinase C isoforms into lysosometargeted endosomes through interaction with p62. Mol Cell Biol. 1998;18:3069-3080. (Pubitemid 28183475)
14. Puls A, Schmidt S, Grawe F, Stabel S. Interaction of protein kinase C zeta with ZIP, a novel protein kinase Cbinding protein. Proc Natl Acad Sci USA. 1997;94:6191-6196.
15. Moscat J, DiazMeco MT, Wooten MW. Of the atypical PKCs, Par4 and p62: recent understandings of the biology and pathology of a PB1dominated complex. Cell Death Differ. 2009;16:1426-1437.
16. Durán A, Serrano M, Leitges M, Flores JM, Picard S, Brown JP, Moscat J, DiazMeco MT. The atypical PKCinteracting protein p62 is an important mediator of RANKactivated osteoclastogenesis. Dev Cell. 2004;6:303-309. (Pubitemid 38190368)
17. Wooten MW, Geetha T, Seibenhener ML, Babu JR, DiazMeco MT, Moscat J. The p62 scaffold regulates nerve growth factorinduced NFkappaB activation by influencing TRAF6 polyubiquitination. J Biol Chem. 2005;280:35625-35629. (Pubitemid 41532755)
18. Martin P, DiazMeco MT, Moscat J. The signaling adapter p62 is an important mediator of T helper 2 cell function and allergic airway inflammation. EMBO J. 2006;25:3524-3533. (Pubitemid 44264863)
19. Duran A, Linares JF, Galvez AS, Wikenheiser K, Flores JM, DiazMeco MT, Moscat J. The signaling adaptor p62 is an important NFkappaB mediator in tumorigenesis. Cancer Cell. 2008;13:343-354. (Pubitemid 351446193)
20. Wang XQ, Nigro P, World C, Fujiwara K, Yan C, Berk BC. Thioredoxin interacting protein promotes endothelial cell inflammation in response to disturbed flow by increasing leukocyte adhesion and repressing Kruppellike factor 2. Circ Res. 2012;110:560-568.
21. Pang J, Hoefen R, Pryhuber GS, Wang J, Yin G, White RJ, Xu X, O'Dell MR, Mohan A, Michaloski H, Massett MP, Yan C, Berk BC. Gproteincoupled receptor kinase interacting protein1 is required for pulmonary vascular development. Circulation. 2009;119:1524-1532.
22. Jin ZG, Lungu AO, Xie L, Wang M, Wong C, Berk BC. Cyclophilin A is a proinflammatory cytokine that activates endothelial cells. Arterioscler Thromb Vasc Biol. 2004;24:1186-1191. (Pubitemid 38880006)
23. Slowik MR, Min W, Ardito T, Karsan A, Kashgarian M, Pober JS. Evidence that tumor necrosis factor triggers apoptosis in human endothelial cells by interleukin1converting enzymelike proteasedependent and independent pathways. Lab Invest. 1997;77:257-267. (Pubitemid 27413538)
24. Guicciardi ME, Gores GJ. Life and death by death receptors. FASEB J. 2009;23:1625-1637.
25. Thorburn A. Death receptorinduced cell killing. Cell Signal. 2004;16:139-144.
26. Jin Z, Li Y, Pitti R, Lawrence D, Pham VC, Lill JR, Ashkenazi A. Cullin3based polyubiquitination and p62dependent aggregation of caspase8 mediate extrinsic apoptosis signaling. Cell. 2009;137:721-735.
27. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNFalphainduced apoptosis by NFkappaB. Science. 1996;274:787-789.
28. Beg AA, Baltimore D. An essential role for NFkappaB in preventing TNFalphainduced cell death. Science. 1996;274:782-784. (Pubitemid 26398258)
29. Mi J, Zhang X, Liu Y, Reddy SK, Rabbani ZN, Sullenger BA, Clary BM. NFkappaB inhibition by an adenovirus expressed aptamer sensitizes TNFalphainduced apoptosis. Biochem Biophys Res Commun. 2007;359:475-480. (Pubitemid 46898974)
30. Duran A, DiazMeco MT, Moscat J. Essential role of RelA Ser311 phosphorylation by zetaPKC in NFkappaB transcriptional activation. EMBO J. 2003;22:3910-3918. (Pubitemid 36975717)
31. Yao H, Hwang JW, Moscat J, DiazMeco MT, Leitges M, Kishore N, Li X, Rahman I. Protein kinase C zeta mediates cigarette smoke/aldehyde and lipopolysaccharideinduced lung inflammation and histone modifications. J Biol Chem. 2010;285:5405-5416.
32. Benayoun B, Baghdiguian S, Lajmanovich A, Bartoli M, Daniele N, Gicquel E, Bourg N, Raynaud F, Pasquier MA, Suel L, Lochmuller H, Lefranc G, Richard I. NFkappaBdependent expression of the antiapoptotic factor cFLIP is regulated by calpain 3, the protein involved in limbgirdle muscular dystrophy type 2A. FASEB J. 2008;22:1521-1529. (Pubitemid 351656792)
33. Wooten MW, Seibenhener ML, Mamidipudi V, DiazMeco MT, Barker PA, Moscat J. The atypical protein kinase Cinteracting protein p62 is a scaffold for NFkappaB activation by nerve growth factor. J Biol Chem. 2001;276:7709-7712.
34. Sanz L, DiazMeco MT, Nakano H, Moscat J. The atypical PKCinteracting protein p62 channels NFkappaB activation by the IL1TRAF6 pathway. EMBO J. 2000;19:1576-1586. (Pubitemid 30182165)
35. Moreno L, Frazziano G, Cogolludo A, Cobeño L, Tamargo J, PerezVizcaino F. Role of protein kinase Czeta and its adaptor protein p62 in voltagegated potassium channel modulation in pulmonary arteries. Mol Pharmacol. 2007;72:1301-1309. (Pubitemid 350012603)
36. Martin P, Villares R, RodriguezMascarenhas S, Zaballos A, Leitges M, Kovac J, Sizing I, Rennert P, Márquez G, MartínezA C, DiazMeco MT, Moscat J. Control of T helper 2 cell function and allergic airway inflammation by PKCzeta. Proc Natl Acad Sci USA. 2005;102:9866-9871. (Pubitemid 40993659)
37. Renauld JC. New insights into the role of cytokines in asthma. J Clin Pathol. 2001;54:577-589.
38. Regala RP, Weems C, Jamieson L, Copland JA, Thompson EA, Fields AP. Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity. J Biol Chem. 2005;280:31109-31115. (Pubitemid 41291846)
39. Erdogan E, Lamark T, StallingsMann M, Lee Jamieson, Pellecchia M, Pellechia M, Thompson EA, Johansen T, Fields AP. Aurothiomalate inhibits transformed growth by targeting the PB1 domain of protein kinase Ciota. J Biol Chem. 2006;281:28450-28459. (Pubitemid 44414558)
40. Regala RP, Thompson EA, Fields AP. Atypical protein kinase C iota expression and aurothiomalate sensitivity in human lung cancer cells. Cancer Res. 2008;68:5888-5895.